{"id":173451,"date":"2026-06-03T16:39:47","date_gmt":"2026-06-03T14:39:47","guid":{"rendered":"https:\/\/www.startupbusiness.it\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/"},"modified":"2026-06-03T19:01:38","modified_gmt":"2026-06-03T17:01:38","slug":"first-exit-for-angelini-ventures-noctrix-acquired-by-resmed","status":"publish","type":"post","link":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/","title":{"rendered":"First exit for Angelini Ventures: Noctrix acquired by ResMed"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Angelini Ventures, the corporate venture capital arm of Angelini Industries, has announced that <a href=\"https:\/\/www.startupbusiness.it\/en\/angelini-ventures-invests-eight-million-euros-in-two-u-s-startups\/129855\/\" target=\"_blank\" rel=\"noreferrer noopener\">Noctrix Health, in which it invested in January 2024<\/a>, has been acquired for $340 million by ResMed, an Australian company headquartered in San Diego, USA, and a leading manufacturer of medical devices for respiratory and sleep-related disorders.<\/p>\n\n<p class=\"wp-block-paragraph\">This transaction marks Angelini Ventures\u2019 first exit from a portfolio company and has come ahead of schedule, confirming the quality of the portfolio, the firm\u2019s ability to identify technologies with significant clinical and market impact, and the team\u2019s strategic and operational expertise.<\/p>\n\n<p class=\"wp-block-paragraph\">In January 2024, Angelini Ventures participated in Noctrix\u2019s capital raise as part of a $40 million Series C round led by Sectoral Asset Management, with participation from Resmed and Asahi Kasei, amongst others, and support from existing investors, including Orbimed and Treo Ventures.<\/p>\n\n<p class=\"wp-block-paragraph\">\u201cThis transaction marks a significant milestone for Angelini Ventures: it is our first exit from a portfolio company, achieved almost a year ahead of schedule,\u201d said Paolo Di Giorgio, CEO of Angelini Ventures, in a statement. \u201cThis is a source of great satisfaction for our company, which has once again demonstrated its ability to identify and support innovative, high-potential technological solutions. It is also further proof of the strength of the Noctrix team, to whom we wish all the best for their future growth. As Angelini Ventures, backed by \u20ac125 million in investments already allocated from 2022 to the present, we remain determined to promote innovation and build a solid infrastructure for investing in new ideas, technologies and partnerships.\u201d  <\/p>\n\n<p class=\"wp-block-paragraph\">\u201cSetting up Angelini Ventures was a forward-thinking decision: we wanted to establish a \u20ac300 million corporate venture capital fund with the aim of investing in innovation and building a stable bridge between research, start-ups and industry at an international level,\u201d says Sergio Marullo di Condojanni, CEO of Angelini Industries \u201cThis first exit confirms the soundness of our approach and the excellent work of the Angelini Ventures team in identifying start-ups and projects with strong growth potential which, we are certain, will help improve people\u2019s quality of life, expanding access to care and promoting more effective care pathways through digital innovation.\u201d<\/p>\n\n<p class=\"wp-block-paragraph\">\u201cIt has been a privilege to work with the Noctrix team at such a crucial stage in the company\u2019s growth,\u201d adds Tanja Dowe, managing director of Angelini Ventures and Observer (pictured) and, until the acquisition, a member of the board of directors at Noctrix Health. \u201cThe speed and quality of their work in clinical development, regulatory approval and commercialisation have been exceptional. We are proud to have supported the company on its journey towards delivering an innovative treatment for patients suffering from Restless Legs Syndrome.\u201d<\/p>\n\n<p class=\"wp-block-paragraph\">Founded in 2016, Noctrix is a US-based medtech company that has developed Nidra, the first wearable device designed to treat Restless Legs Syndrome (RLS), a neurological disorder that causes uncomfortable sensations in the lower limbs, which occur mainly at night and negatively affect sleep quality. The wearable therapy, based on Tonic Motor Activation (TOMAC), involves the use of two bands, to be worn just below the knees, which contain a device capable of stimulating the spinal cord via electrical pulses, thereby generating a response that activates the muscles in the lower legs, reducing symptoms and improving sleep quality in adults with drug-resistant RLS. Nidra was authorised in 2023 by the Food and Drug Administration (FDA) via the De Novo pathway for medical devices, supporting its marketing in the United States: it is the first and only treatment approved by the US federal agency for RLS.  <\/p>\n\n<p class=\"wp-block-paragraph\">Resmed plans to integrate Noctrix\u2019s technology into its portfolio of connected devices and digital health solutions to help expand access, improve care pathways and enhance patient outcomes over time. This approach resonates deeply with Angelini Ventures\u2019 vision regarding connected devices and digital health and represents a concrete demonstration of an investment strategy capable of creating value for patients and for the healthcare system as a whole, going beyond traditional implantable and non-connected devices. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>The deal is worth $340 million and was completed in the US; Angelini Ventures had originally invested in 2024<\/p>\n","protected":false},"author":125,"featured_media":173444,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"_acf_changed":false,"_substack_draft_id":"","_substack_draft_url":"","_substack_last_pushed":"","_substack_premium":"","footnotes":""},"categories":[1317],"tags":[1743,1486,1492,1143,1323],"companies":[2384],"journalist":[1518],"class_list":["post-173451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-news","tag-corporate-venture-en","tag-exit-en","tag-healtcare-en","tag-investments","tag-scaleup-en","companies-angelini-ventures-en","journalist-editorial-staff-en"],"featured_sizes_urls":{"thumbnail":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","width":150,"height":128,"crop":false,"srcset":false,"alt":"angelini exit"},"large":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","width":1024,"height":874,"crop":false,"srcset":false,"alt":"angelini exit"},"2048x2048":{"src":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","width":1076,"height":918,"crop":false,"srcset":false,"alt":"angelini exit"}},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>First exit for Angelini Ventures: Noctrix acquired by ResMed<\/title>\n<meta name=\"description\" content=\"The deal is worth $340 million and was completed in the US; Angelini Ventures had originally invested in 2024\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First exit for Angelini Ventures: Noctrix acquired by ResMed\" \/>\n<meta property=\"og:description\" content=\"The deal is worth $340 million and was completed in the US; Angelini Ventures had originally invested in 2024\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/\" \/>\n<meta property=\"og:site_name\" content=\"Startupbusiness.it\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-03T14:39:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-03T17:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1076\" \/>\n\t<meta property=\"og:image:height\" content=\"918\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emil Abirascid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@emilabirascid\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emil Abirascid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/\"},\"author\":{\"name\":\"Emil Abirascid\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"headline\":\"First exit for Angelini Ventures: Noctrix acquired by ResMed\",\"datePublished\":\"2026-06-03T14:39:47+00:00\",\"dateModified\":\"2026-06-03T17:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/\"},\"wordCount\":663,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/angelini-piccola.jpg\",\"keywords\":[\"corporate venture\",\"exit\",\"Healtcare\",\"investments\",\"Scaleup\"],\"articleSection\":[\"Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/\",\"name\":\"First exit for Angelini Ventures: Noctrix acquired by ResMed\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/angelini-piccola.jpg\",\"datePublished\":\"2026-06-03T14:39:47+00:00\",\"dateModified\":\"2026-06-03T17:01:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\"},\"description\":\"The deal is worth $340 million and was completed in the US; Angelini Ventures had originally invested in 2024\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\\\/173451\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/angelini-piccola.jpg\",\"contentUrl\":\"https:\\\/\\\/www.startupbusiness.it\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/angelini-piccola.jpg\",\"width\":1076,\"height\":918,\"caption\":\"angelini exit\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/\",\"name\":\"Startupbusiness.it\",\"description\":\"May the Force be with you!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/#\\\/schema\\\/person\\\/4e2760db2cb7ca47d635ea3d8d8486dd\",\"name\":\"Emil Abirascid\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac925fb049ca749d7e16a36a75fbc9bf342bb19b7c22dae55be274ab4557890a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac925fb049ca749d7e16a36a75fbc9bf342bb19b7c22dae55be274ab4557890a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac925fb049ca749d7e16a36a75fbc9bf342bb19b7c22dae55be274ab4557890a?s=96&d=mm&r=g\",\"caption\":\"Emil Abirascid\"},\"description\":\"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.\",\"sameAs\":[\"https:\\\/\\\/www.abirascid.com\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/emilabirascid\",\"https:\\\/\\\/x.com\\\/emilabirascid\"],\"url\":\"https:\\\/\\\/www.startupbusiness.it\\\/en\\\/author\\\/emil-abirascid\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"First exit for Angelini Ventures: Noctrix acquired by ResMed","description":"The deal is worth $340 million and was completed in the US; Angelini Ventures had originally invested in 2024","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/","og_locale":"en_US","og_type":"article","og_title":"First exit for Angelini Ventures: Noctrix acquired by ResMed","og_description":"The deal is worth $340 million and was completed in the US; Angelini Ventures had originally invested in 2024","og_url":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/","og_site_name":"Startupbusiness.it","article_published_time":"2026-06-03T14:39:47+00:00","article_modified_time":"2026-06-03T17:01:38+00:00","og_image":[{"width":1076,"height":918,"url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","type":"image\/jpeg"}],"author":"Emil Abirascid","twitter_card":"summary_large_image","twitter_creator":"@emilabirascid","twitter_misc":{"Written by":"Emil Abirascid","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/#article","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/"},"author":{"name":"Emil Abirascid","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"headline":"First exit for Angelini Ventures: Noctrix acquired by ResMed","datePublished":"2026-06-03T14:39:47+00:00","dateModified":"2026-06-03T17:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/"},"wordCount":663,"commentCount":0,"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","keywords":["corporate venture","exit","Healtcare","investments","Scaleup"],"articleSection":["Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/","url":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/","name":"First exit for Angelini Ventures: Noctrix acquired by ResMed","isPartOf":{"@id":"https:\/\/www.startupbusiness.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/#primaryimage"},"image":{"@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/#primaryimage"},"thumbnailUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","datePublished":"2026-06-03T14:39:47+00:00","dateModified":"2026-06-03T17:01:38+00:00","author":{"@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd"},"description":"The deal is worth $340 million and was completed in the US; Angelini Ventures had originally invested in 2024","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.startupbusiness.it\/en\/first-exit-for-angelini-ventures-noctrix-acquired-by-resmed\/173451\/#primaryimage","url":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","contentUrl":"https:\/\/www.startupbusiness.it\/wp-content\/uploads\/2026\/06\/angelini-piccola.jpg","width":1076,"height":918,"caption":"angelini exit"},{"@type":"WebSite","@id":"https:\/\/www.startupbusiness.it\/en\/#website","url":"https:\/\/www.startupbusiness.it\/en\/","name":"Startupbusiness.it","description":"May the Force be with you!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.startupbusiness.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.startupbusiness.it\/en\/#\/schema\/person\/4e2760db2cb7ca47d635ea3d8d8486dd","name":"Emil Abirascid","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ac925fb049ca749d7e16a36a75fbc9bf342bb19b7c22dae55be274ab4557890a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ac925fb049ca749d7e16a36a75fbc9bf342bb19b7c22dae55be274ab4557890a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ac925fb049ca749d7e16a36a75fbc9bf342bb19b7c22dae55be274ab4557890a?s=96&d=mm&r=g","caption":"Emil Abirascid"},"description":"Emil Abirascid (\u30a8\u30df\u30fc\u30eb\u30fb\u30a2\u30d3\u30e9\u30b7\u30c3\u30c9), giornalista, fondatore e direttore di Startupbusiness, il primo magazine sull\u2019ecosistema startup e innovazione italiano. Co-fondatore di Designtech, l\u2019hub di innovazione che avvicina il mondo del design con quello della tecnologia. Advisor di Austrian Business Agency, Emil Banca, Fondazione Symbola, Fondazione Quadrans. Partecipa regolarmente a incontri, convegni, conferenze dedicate all\u2019ecosistema dell\u2019innovazione. E\u2019 stato co-organizzatore degli Italian Innovation Day and Series che si sono svolti dal dal 2016 al 2020 nelle citt\u00e0 di Tokyo in Giappone, Melbourne, Adelaide, Perth, Canberra in Australia e Singapore e co-organizzatore dell\u2019Italy India Innovation Day di AIICP 2021 e 2022. Ha curato il volume \u2018L\u2019innovazione che non ti aspetti. Contesti e visioni per l\u2019impresa\u2019 , l\u2019edizione italiana di \u2018La startup digitale, guida pratica step by step\u2019 e ha scritto la prefazione all\u2019edizione italiana de \u2018La quarta era\u2019 di Byron Reese, ed \u00e8 co-autore di \u2018Cosa e Dove: strategie digitali di ricerca del lavoro\u2019, tutti editi da FrancoAngeli. In passato \u00e8 stato curatore di StartupDigest Italy, coordinatore scientifico del Forum per la Ricerca della Provincia Autonoma di Trento, board member di TechChill Milano advisor di di ScaleIT , ha collaborato con Il Sole 24 Ore \u00e8 stato direttore di Innov\u2019azione, bimestrale edito da Apsti, ha collaborato con Corriere Innovazione ed \u00e8 stato presidente del comitato di selezione del Premio Marzotto e advisor di Cetif-Universit\u00e0 Cattolica Milano.","sameAs":["https:\/\/www.abirascid.com\/","https:\/\/www.linkedin.com\/in\/emilabirascid","https:\/\/x.com\/emilabirascid"],"url":"https:\/\/www.startupbusiness.it\/en\/author\/emil-abirascid\/"}]}},"author_name":"Emil Abirascid","categories_names":["Funding News"],"_links":{"self":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/173451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/comments?post=173451"}],"version-history":[{"count":1,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/173451\/revisions"}],"predecessor-version":[{"id":173453,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/posts\/173451\/revisions\/173453"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media\/173444"}],"wp:attachment":[{"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/media?parent=173451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/categories?post=173451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/tags?post=173451"},{"taxonomy":"companies","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/companies?post=173451"},{"taxonomy":"journalist","embeddable":true,"href":"https:\/\/www.startupbusiness.it\/en\/wp-json\/wp\/v2\/journalist?post=173451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}